Larimar Therapeutics, Inc. (LRMR)
2.695
-0.04
(-1.28%)
USD |
NASDAQ |
Nov 12, 16:00
2.695
0.00 (0.00%)
After-Hours: 17:33
Larimar Therapeutics Price : 2.695 for Nov. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 11, 2026 | 2.72 | 2.83 | 2.60 | 2.73 | 1.157M |
| Nov 10, 2026 | 2.50 | 2.735 | 2.46 | 2.69 | 739208.0 |
| Nov 09, 2026 | 2.47 | 2.58 | 2.37 | 2.53 | 693927.0 |
| Nov 06, 2026 | 2.355 | 2.475 | 2.30 | 2.39 | 973641.0 |
| Nov 05, 2026 | 2.76 | 2.83 | 2.26 | 2.32 | 1.773M |
| Nov 04, 2026 | 2.60 | 2.78 | 2.57 | 2.76 | 1.992M |
| Nov 03, 2026 | 2.39 | 2.62 | 2.323 | 2.54 | 1.648M |
| Nov 02, 2026 | 2.49 | 2.566 | 2.34 | 2.37 | 667726.0 |
| Oct 30, 2026 | 2.64 | 2.655 | 2.42 | 2.47 | 781280.0 |
| Oct 29, 2026 | 2.57 | 2.73 | 2.558 | 2.67 | 1.027M |
| Oct 28, 2026 | 2.375 | 2.55 | 2.31 | 2.54 | 809780.0 |
| Oct 27, 2026 | 2.25 | 2.41 | 2.21 | 2.39 | 1.205M |
| Oct 26, 2026 | 2.35 | 2.39 | 2.18 | 2.24 | 1.310M |
| Oct 23, 2026 | 2.27 | 2.37 | 2.22 | 2.35 | 1.144M |
| Oct 22, 2026 | 2.40 | 2.509 | 2.235 | 2.27 | 1.764M |
| Oct 21, 2026 | 2.40 | 2.54 | 2.39 | 2.42 | 1.513M |
| Oct 20, 2026 | 2.12 | 2.49 | 2.10 | 2.44 | 1.811M |
| Oct 19, 2026 | 1.99 | 2.175 | 1.96 | 2.12 | 1.231M |
| Oct 16, 2026 | 2.05 | 2.07 | 1.915 | 1.985 | 1.692M |
| Oct 15, 2026 | 2.09 | 2.115 | 1.95 | 1.99 | 6.180M |
| Oct 14, 2026 | 2.15 | 2.22 | 2.06 | 2.09 | 2.257M |
| Oct 13, 2026 | 2.53 | 2.53 | 2.13 | 2.16 | 2.573M |
| Oct 12, 2026 | 2.66 | 2.69 | 2.53 | 2.53 | 952184.0 |
| Oct 09, 2026 | 2.68 | 2.74 | 2.62 | 2.67 | 868878.0 |
| Oct 08, 2026 | 2.72 | 2.74 | 2.61 | 2.70 | 1.191M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 18.12 |
| Alnylam Pharmaceuticals, Inc. | 156.59 |
| Anika Therapeutics, Inc. | 13.84 |
| Savara, Inc. | 4.71 |
| Vericel Corp. | 57.40 |
Price Related Metrics
| PEG Ratio | -0.0503 |
| Price to Book Value | 2.208 |
| Earnings Yield | -73.58% |
| Market Cap | 281.31M |
| PEGY Ratio | -0.0503 |